<?xml version="1.0" encoding="UTF-8"?>
<ref id="B45-tropicalmed-04-00104">
 <label>45.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Modjarrad</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>George</surname>
    <given-names>S.L.</given-names>
   </name>
   <name>
    <surname>Stephenson</surname>
    <given-names>K.E.</given-names>
   </name>
   <name>
    <surname>Eckels</surname>
    <given-names>K.H.</given-names>
   </name>
   <name>
    <surname>De La Barrera</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Jarman</surname>
    <given-names>R.G.</given-names>
   </name>
   <name>
    <surname>Sondergaard</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Tennant</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Ansel</surname>
    <given-names>J.L.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: Phase 1, randomised, double-blind, placebo-controlled clinical trials</article-title>
  <source>Lancet</source>
  <year>2018</year>
  <volume>391</volume>
  <fpage>10120</fpage>
  <pub-id pub-id-type="doi">10.1016/S0140-6736(17)33106-9</pub-id>
 </element-citation>
</ref>
